Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2012 Oct;43(3):322-30.
doi: 10.1016/j.jsat.2012.01.004. Epub 2012 Feb 27.

Project Impact: a pharmacotherapy pilot trial investigating the abstinence and treatment adherence of Latino light smokers

Marcel A de Dios  1 , Bradley J Anderson, Cassandra Stanton, Daniel A Audet, Michael Stein
Affiliations
Randomized Controlled Trial

Project Impact: a pharmacotherapy pilot trial investigating the abstinence and treatment adherence of Latino light smokers

Marcel A de Dios et al. J Subst Abuse Treat. 2012 Oct.

Abstract

Light smoking is particularly prevalent among Latino smokers. Nicotine replacement (NRT) and varenicline are effective medications for smoking cessation for moderate-heavy smokers but have not been tested in light smokers, and thus, there are no treatment guidelines for use with light smokers. This pilot trial tested the efficacy of NRT and varenicline in increasing smoking abstinence among Latino light smokers. A 3-group (NRT, varenicline, and varenicline-placebo) randomized design was used, and Latino light smokers (≤10 cigarettes per day) received 12 weeks of treatment, which included a culturally informed behavioral health session and ongoing medication management visits. At follow-up, there were no abstinent participants in the placebo and NRT groups. However, 30% of participants in the varenicline group were abstinent at the 3-, 4-, and 6-month follow-up. This study represents the only investigation that specifically targets Latino light smokers using these treatments and characterizing their treatment adherence.

PubMed Disclaimer

Conflict of interest statement

The authors of this manuscript do not have any conflicts of interest to declare.

References

    1. Ahluwalia J, Okuyemi K, Nollen N, Choi W, Kaur H, Pulvers K, et al. The effects of nicotine gum and counseling among African American light smokers: a 2 × 2 factorial design. Addiction. 2006;101(6):883–891. - PubMed
    1. Benowitz NL, Bernert JT, Caraballo RS, Holiday DB, Wang J. Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within different racial/ethnic groups in the United States between 1999 and 2004. Am J Epidemiol. 2009;169(2):236–248. - PubMed
    1. Borrelli B, McQuaid EL, Novak SP, Hammond SK, Becker B. Motivating Latino caregivers of children with asthma to quit smoking: a randomized trial. J Consult Clin Psychol. 2010;78(1):34–43. - PubMed
    1. Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2008;3 CD006103. - PubMed
    1. Catz SL, Jack LM, McClure JB, Javitz HS, Deprey M, Zbikowski SM, et al. Adherence to Varenicline in the COMPASS Smoking Cessation Intervention Trial. Nicotine Tob Res. 2011;13(5):361–368. - PMC - PubMed

Publication types

MeSH terms